Lymphoma
The crowd matters.
For far too long, we the people who want to give and get better care have had no say in what new ideas get into practice. When you support new ideas here they are over 20 times more likely to get out to market - sometimes incredibly fast. So explore, like, try, pilot, partner, mentor, or invest in these companies and ideas and let's fix healthcare, one awesome idea at a time!
See the companies ↓Part of Hematologic Malignancies
Fyggy's top 2 in Lymphoma
Ranked by MedStartr Engagement Score.
- 1Biostate AIMedStartr Engagement Score38MedStartr Engagement Score38
- 2ImpriMedMedStartr Engagement Score5MedStartr Engagement Score5
Companies in Lymphoma
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Only accessible to MedStartr community members.
Join nowBiostate AI
Houston, TX, US
Biostate AI combines RNA sequencing technology with artificial intelligence for disease diagnosis and drug response prediction. The company has invented and patented novel biomo...
...moreSource: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →Only accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowRelated Companies
Semantically similar companies discovered by AI
Only accessible to MedStartr community members.
Join now
OncoLens
Atlanta, Georgia, United States
A precision oncology solutions company.
Only accessible to MedStartr community members.
Join now
Only accessible to MedStartr community members.
Join now
Delfi Diagnostics
Palo Alto, California, United States
Delfi Diagnostics focuses on early cancer detection using machine learning.
Only accessible to MedStartr community members.
Join nowRelated Disease Areas
Lymphoma Salon
Share photos and talk with people who care about Lymphoma. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment